[ad_1]
AGI – The European Commission today presented its legislative proposal to create a vaccination certificate, the “Digital Green Certificate”, for Facilitate safe free movement within the EU. in times of the Covid-19 pandemic. Not only will it demonstrate the vaccine, but it will also provide details (in the absence of vaccination) on the negative test for Covid (including rapid ones) or on the presence of curative antibodies. Effective mid-June, will be available, free of charge, in digital or paper format.
The security and authenticity of the certificate will be guaranteed by a QR Code that can be used to verify the presence of data in the databases. The Commission will establish a gateway to ensure that all certificates can be verified across the EU and will assist Member States in the technical implementation of the certificates. States are still responsible for deciding which restrictions to ease on travelers, but they must be the same for all green certificate holders..
“This is an EU-level approach to issue, verify and accept certificates to facilitate free movement within the EU, based on strict compliance with non-discrimination and fundamental rights of EU citizens,” explains the Commission. “A technical framework will be defined at the EU level, which will be launched in mid-June, to guarantee security, interoperability and full respect for the protection of personal data. It will also allow to extend the possibility to compatible certificates. issued in third countries ”, they add from Brussels.
“With the green certificate, the goal is to restore traffic safely, responsibly and reliably,” said the President of the European Commission, Ursula von der Leyen. “The objective is to reopen,” he added. “THEor I trust AstraZeneca, I trust their vaccine. Ema will make another statement tomorrow and I am convinced that it will allow us to clarify the situation ”. This was stated by the president of the European Commission, Ursula von der Leyen, regarding the reports of suspected cases of side effects.
The President of the Commission has confirmed the goal of “vaccinating 70% of the EU population over 18 by summer” while acknowledging AstraZeneca dose delivery problems. Among the pharmaceutical companies with which the EU has concluded agreements, explains von der Leyen, “there are different levels of reliability in the supply” because “BioNTech / Pfizer and Moderna are very reliable, AstraZeneca is not”. The president thus explained the different ‘mix’ of orders from member countries that occurred because “not all member states bought the amounts they owed” to each country in proportion to the population and therefore some governments “bought more doses” than they remain on the market for other countries.
Von der Leyen then said that 10 million doses have been exported to the UK in recent weeks, which is the first recipient of doses for the European Union, even though the UK produces doses of AstraZeneca “and” our contract mentions two plants in Great Britain that should also produce doses for the EU, but we are still waiting “, then “There is no reciprocity” in the deal between London and Brussels. The president raised the hypothesis of new control mechanisms on the export of doses to countries that do not guarantee reciprocity. Unlike the United Kingdom, “there is reciprocity with the United States” because “although there are restrictions on trade in doses,” from the United States “come a series of components” necessary for the production of vaccines in the EU.
